Welcure Drugs & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve Audited Financial ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Welcure Drugs & Pharmaceuticals Ltd has announced that its Board of Directors meeting is scheduled for 29th May 2026 at the company's registered office in Delhi. The meeting will consider and approve the audited financial results for the quarter and year ended 31st March 2026. The board will also take on record the statutory auditors' audit report and approve the complete audited financial statements including the balance sheet, profit and loss statement, and cash flow statement for FY2026. This is a standard regulatory filing under SEBI (LODR) Regulations.
This is a routine board meeting intimation for annual audited results. No specific financial details orarnings figures are disclosed at this stage. The actual results will be announced after the board meeting takes place on 29th May 2026.